Klingman & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $418K | Buy |
6,055
+2,753
| +83% | +$190K | 0.02% | 189 |
|
|
2025
Q1 | $229K | Buy |
3,302
+397
| +14% | +$27.6K | 0.01% | 246 |
|
|
2024
Q4 | $250K | Buy |
2,905
+398
| +16% | +$34.2K | 0.02% | 227 |
|
|
2024
Q3 | $299K | Sell |
2,507
-15
| -0.6% | -$1.79K | 0.02% | 216 |
|
|
2024
Q2 | $360K | Buy |
2,522
+730
| +41% | +$104K | 0.02% | 173 |
|
|
2024
Q1 | $230K | Buy |
+1,792
| New | +$230K | 0.02% | 220 |
|